Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nu Skin Enterprises Inc. (NUS:NYSE), powered by AI.
Nu Skin Enterprises Inc. is currently trading at $5.05. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Nu Skin Enterprises Inc. on Alpha Lenz.
Nu Skin Enterprises Inc.'s P/E ratio is 1.6.
“Nu Skin Enterprises Inc. trades at a P/E of 1.6 (undervalued) with strong ROE of 22.0%.”
Ask for details →Nu Skin Enterprises Inc. is a global direct selling company specializing in the marketing and distribution of premium-quality personal care products and dietary supplements. The company's primary purpose is to empower individuals by providing them with the opportunity to run personal businesses by selling its diverse array of beauty and wellness products. Notably, it operates in sectors like skincare, health and nutrition, aiming to promote healthier lifestyles and aging solutions. Nu Skin leverages a unique business model, combining innovative product development with a robust, entrepreneur-focused sales strategy. This model not only impacts individuals at the grassroots level by fostering entrepreneurial initiatives but also significantly influences the larger market trends in nutraceuticals and personal care. Established in 1984 and headquartered in Provo, Utah, Nu Skin has expanded its reach globally, with operations in multiple international markets. It is recognized for its commitment to quality and sustainability, integrating cutting-edge scientific research into its product offerings while maintaining a strong presence in the competitive direct selling industry.
“Nu Skin Enterprises Inc. trades at a P/E of 1.6 (undervalued) with strong ROE of 22.0%.”
Ask for details →Nu Skin Enterprises Inc. (ticker: NUS) is a company listed on NYSE in the Consumer Defensive sector (Household & Personal Products). It has approximately 3,100 employees. Market cap is $249M.
The current price is $5.05 with a P/E ratio of 1.55x and P/B of 0.31x.
ROE is 22.00% and operating margin is 6.12%. Annual revenue is $1.5B.